Trial NCT03252171

View at ClinicalTrials.gov 
Org. Study IDs: CAR-T for GD2 positive glioma

Last trial update was posted on 2020-07-16

MeSH Interventions

Immunomodulating Agents

MeSH Conditions

Glioma

Other Conditions

CAR-T Cell Immunotherapy GD2 Positive Glioma

Stopping Reasons

Project terminated due to revision of local regulations

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID